Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODIES AND METHODS FOR TREATING CLAUDIN-ASSOCIATED DISEASES
Document Type and Number:
WIPO Patent Application WO/2021/259304
Kind Code:
A1
Abstract:
Provided are anti-CLDN18 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

Inventors:
HOU BING (CN)
CHEN PENG (CN)
YUWEN HUI (CN)
SHAN BO (CN)
MEI JAY (CN)
Application Number:
PCT/CN2021/101713
Publication Date:
December 30, 2021
Filing Date:
June 23, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ANTENGENE HANGZHOU BIOLOGICS CO LTD (CN)
ANTENGENE BIOLOGICS LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61K45/06; A61P35/00; G01N33/574; G01N33/68
Domestic Patent References:
WO2014146778A12014-09-25
WO2018123949A12018-07-05
Foreign References:
CN109762067A2019-05-17
Other References:
PRABHSIMRANJOT SINGH, SUDHAMSHI TOOM , YIWU HUANG: "Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer", JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 10, 12 May 2017 (2017-05-12), pages 1 - 5, XP055630965, DOI: 10.1186/s13045-017-0473-4
JULIA HOLLAND: "DEVELOPMENT OF A HIGHLY POTENT BISPECIFIC ANTIBODY FORMAT TARGETING THE NOVEL TUMOR-SPECIFIC ANTIGEN CLDN18.2", 16 December 2014 (2014-12-16), XP055630966, Retrieved from the Internet [retrieved on 20191010]
KURAOKA,M. ET AL.: "Immunoglobulin Heavy Chain Variable Region, Partial [Mus Musculus]", GENBANK: AML31651.1, 10 March 2016 (2016-03-10), XP55882943
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF: